A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature
Top Cited Papers
Open Access
- 15 July 2007
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 110 (2), 578-586
- https://doi.org/10.1182/blood-2006-07-036228
Abstract
How receptor acquisition correlates with the functional maturation of natural killer (NK) cells is poorly understood. We used quantitative real-time polymerase chain reaction (PCR) assays to compare NKG2 and killer immunoglobulin-like receptor (KIR) gene expression in NK cells from allogeneic transplant recipients and their donors. Marked differences were observed in the NK subsets of recipients who had 8-fold more CD56bright cells, diminished KIR expression (except 2DL4), and increased NKG2A. In normal blood not all CD56dim cells express KIR, and a novel subpopulation of cells committed to the NK-cell lineage was defined. These cells, which comprise 19.4% ± 2.8% of the CD56dim NK population in healthy donors, express the activating NKG2D and NKG2E receptors but no KIR or NKG2A. Although the CD56dim NKG2A− KIR− NK cells lack “at least one” inhibitory receptor for autologous MHC class I, they are not fully responsive, but rather functionally immature cells with poor cytotoxicity and IFN-γ production. Upon culture with IL-15 and a stromal cell line, CD56dim and CD56bright KIR− NK cells proliferate, express KIR, and develop cytotoxicity and cytokine-producing potential. These findings have implications for the function of NK cells reconstituting after transplantation and support a model for in vivo development in which CD56bright cells precede CD56dim cells.Keywords
This publication has 49 references indexed in Scilit:
- SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivationNature Genetics, 2008
- Non-MHC ligands for inhibitory immune receptors: Novel insights and implications for immune regulationMolecular Immunology, 2007
- Taking license with natural killer cell maturation and repertoire developmentImmunological Reviews, 2006
- Activation and self‐tolerance of natural killer cellsImmunological Reviews, 2006
- Evidence for discrete stages of human natural killer cell differentiation in vivoThe Journal of Experimental Medicine, 2006
- Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancerBlood, 2005
- A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer CellsImmunity, 2005
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- Arousal and inhibition of human NK cellsImmunological Reviews, 1997
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990